Arrhythmogenic Right Ventricular Cardiomyopathy: Progress Toward Personalized Management
Cynthia A James1, Hugh Calkins1
1Division of Cardiology, Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA; email: cjames7@jhmi.edu , hcalkins@jhmi.edu.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited heart condition. New research offers personalized management strategies for patients and families by understanding genetic and environmental factors.
Area of Science:
- Cardiology
- Genetics
- Inherited Cardiac Diseases
Background:
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited heart disease.
- It involves fibrofatty replacement of the ventricular myocardium, leading to arrhythmias and dysfunction.
- Optimal management strategies for ARVC are still undefined.
Purpose of the Study:
- To review current understanding of ARVC.
- To explore how new insights can personalize management.
- To guide longitudinal screening for at-risk families.
Main Methods:
- Review of natural history studies.
- Analysis of pathogenic mechanisms.
- Evaluation of genetic and environmental modifiers.
Main Results:
- ARVC is linked to pathogenic variants in cardiac desmosome genes.
- Genetic testing identifies at-risk individuals, but penetrance is unpredictable.
- Endurance exercise is a key risk factor, but disease development varies.
Conclusions:
- Personalized management approaches for ARVC are emerging.
- Integrating genetic, environmental, and clinical data is crucial.
- Improved understanding facilitates better screening and care for affected families.
Related Concept Videos
Cardiomyopathy VI: Nursing Management
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care


